# Study of Serum Tumor Markers of HBV Associated HCC

> **NCT05825196** · — · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 164 (estimated)

## Conditions studied

- HCC

## Interventions

- **DIAGNOSTIC_TEST:** tumor tissue and blood tests

## Key facts

- **NCT ID:** NCT05825196
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05825196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05825196, "Study of Serum Tumor Markers of HBV Associated HCC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05825196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*